PMID- 36825521
OWN - NLM
STAT- MEDLINE
DCOM- 20240118
LR  - 20240118
IS  - 1940-1574 (Electronic)
IS  - 0003-3197 (Linking)
VI  - 75
IP  - 3
DP  - 2024 Mar
TI  - Risk Factors for 30-day Hospital Readmissions After Peripheral Vascular 
      Interventions in Peripheral Artery Disease Patients at the US-Mexico Border.
PG  - 240-248
LID - 10.1177/00033197221146161 [doi]
AB  - Peripheral artery disease (PAD) is associated with high rates of readmission 
      following endovascular interventions and contributes to a significant hospital 
      readmission burden. Quality metrics like hospital readmissions affect hospital 
      performance, but must adjust to local trends. Our primary goal was to evaluate 
      risk factors and readmission rates post-percutaneous peripheral intervention in a 
      US-Mexico border city, at a single tertiary university hospital. We performed a 
      retrospective review of patients with PAD undergoing first time peripheral 
      intervention from July 2015 to June 2020. Among 212 patients, 58% were readmitted 
      with median 235-day follow-up (inter-quartile range (IQR) 42-924); 35.3% of 
      readmissions occurred within 30 days, and 30.2% of those were within 7 days. 
      Median time to readmission was 62 days. Active smokers had 84% higher risk of 
      readmission (hazard ratio (HR) 1.84, 95% CI 1.23-2.74, P < .01). Other 
      significant factors noted were insurance status-Medicaid or uninsured (HR 1.94, 
      95% CI 1.22-3.09), prior amputation (HR 1.69, 95% CI 1.13-2.54), heart failure, 
      both preserved (HR 4.35, 95% CI 2.07-9.16) and reduced ejection fraction (HR 
      1.88, 95% CI 1.14-3.10). Below the knee, interventions were less likely to be 
      readmitted (adjusted HR .64, 95% CI 0.42-.96). Readmission rates were unrelated 
      to medication adherence.
FAU - Mishra, Kunal
AU  - Mishra K
AUID- ORCID: 0000-0002-0112-6049
AD  - Department of Internal Medicine, Texas Tech University Health Sciences Center, El 
      Paso, TX, USA. RINGGOLD: 37316
FAU - Mohammad, Khan O
AU  - Mohammad KO
AD  - Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, 
      El Paso, TX, USA. RINGGOLD: 21976
FAU - Patel, Divyank
AU  - Patel D
AD  - Department of Internal Medicine, Texas Tech University Health Sciences Center, El 
      Paso, TX, USA. RINGGOLD: 37316
FAU - Makhija, Rakhee
AU  - Makhija R
AD  - Division of Cardiovascular Medicine, Department of Internal Medicine, Texas Tech 
      University Health Sciences Center, El Paso, TX, USA. RINGGOLD: 37316
FAU - Siddiqui, Tariq
AU  - Siddiqui T
AD  - Division of Cardiovascular Medicine, Department of Internal Medicine, Texas Tech 
      University Health Sciences Center, El Paso, TX, USA. RINGGOLD: 37316
FAU - Abolbashari, Mehran
AU  - Abolbashari M
AD  - Division of Cardiovascular Medicine, Department of Internal Medicine, Texas Tech 
      University Health Sciences Center, El Paso, TX, USA. RINGGOLD: 37316
FAU - Cruz Rodriguez, Jose B
AU  - Cruz Rodriguez JB
AD  - Division of Cardiovascular Medicine, Department of Internal Medicine, Texas Tech 
      University Health Sciences Center, El Paso, TX, USA. RINGGOLD: 37316
AD  - Division of Cardiovascular Medicine, Department of Medicine, University of 
      California San Diego, San Diego, CA, USA. RINGGOLD: 8784
LA  - eng
PT  - Journal Article
DEP - 20230224
PL  - United States
TA  - Angiology
JT  - Angiology
JID - 0203706
SB  - IM
MH  - United States
MH  - Humans
MH  - *Patient Readmission
MH  - Mexico/epidemiology
MH  - Treatment Outcome
MH  - *Peripheral Arterial Disease/therapy
MH  - Risk Factors
MH  - Hospitals
MH  - Retrospective Studies
OTO - NOTNLM
OT  - US-Mexico border
OT  - critical limb ischemia
OT  - peripheral angiographic intervention
OT  - peripheral artery disease
OT  - readmission rates
COIS- Declaration of Conflicting InterestsThe author(s) declared no potential conflicts 
      of interest with respect to the research, authorship, and/or publication of this 
      article.
EDAT- 2023/02/25 06:00
MHDA- 2024/01/18 06:42
CRDT- 2023/02/24 05:14
PHST- 2024/01/18 06:42 [medline]
PHST- 2023/02/25 06:00 [pubmed]
PHST- 2023/02/24 05:14 [entrez]
AID - 10.1177/00033197221146161 [doi]
PST - ppublish
SO  - Angiology. 2024 Mar;75(3):240-248. doi: 10.1177/00033197221146161. Epub 2023 Feb 
      24.